In a recent decision, the Court of Special Appeals of Maryland reviewed an asbestos case involving the death of an employee from mesothelioma. In Stein v. Pfizer, Inc. (Md. Ct. Spec. App. May 31, 2016), the employee worked as a bricklayer, using asbestos-containing cement in completing projects for his employer. After the employee’s death, his family and estate brought negligence and other liability claims against several defendants, including the parent company of the cement product’s manufacturer, alleging that it was an apparent manufacturer and therefore liable for the illness and death of the employee.
In Stein, the estate argued that the defendant held itself out as a manufacturer of the asbestos-containing cement because its trademark was in advertisements and promotional materials for the product. The defendant argued that it was a separate corporation from its subsidiary, that none of the manufacturer’s employees held positions with the defendant, and that only a few of the defendant’s employees sat on the manufacturer’s board of directors. The defendant’s motion for summary judgment was granted by the trial court, which found that, under all of the circumstances, a reasonable person could not conclude from the documents that the defendant was the manufacturer of the product at issue. The plaintiffs appealed the decision.
The Court of Special Appeals examined the history and case law pertaining to the apparent manufacturer doctrine, which holds a non-manufacturer liable for a defective product based on its conduct. The court went on to note that there are three tests for determining whether an entity may be found to be an apparent manufacturer, although Maryland case law does not specify which test is to be applied. Nevertheless, the court concluded that under all three tests, the defendant would not be deemed an apparent manufacturer of the asbestos-containing cement.